Request Clinical Starter Kits for Your Patients Today! Request Now

Are you a clinician?

This is a clinician-only website.
By entering, you acknowledge that you're a clinician.

ENDUR-ACIN® exhibits intermediate release profile for nicotinic acid, study shows

Highlights

  • ENDUR-ACIN® shows an intermediate-release profile for nicotinic acid
  • Peak serum concentration of nicotinic acid achieved at approximately 6 hours
  • Tablet dissolution occurs over 6-8 hours

Summary

 

 

Reference

Ivanovskaya EA, et al. Quantitative determination of ENDUR-ACIN in blood serum (translated from Russian). Pharmaceutical Chem J. 1998;32:48-9.